Pharmacologic Treatments for Females with Menopausal Vasomotor Symptoms: A Clinical Guideline from the American College of Physicians

The American College of Physicians (ACP) recommends estrogen in combination with progestogen (for females with a uterus) or estrogen monotherapy (for females without a uterus) as first-line treatment for perimenopausal and postmenopausal females who are seeking treatment for menopausal vasomotor symptoms (VMS), which consist of hot flashes and night sweats. 

The American College of Physicians (ACP) recommends estrogen in combination with progestogen (for females with a uterus) or estrogen monotherapy (for females without a uterus) as first-line treatment for perimenopausal and postmenopausal females who are seeking treatment for menopausal vasomotor symptoms (VMS), which consist of hot flashes and night sweats. 

Reyna Howkins

hormone replacement therapy; hormone therapy; menopause treatment; vasomotor symptoms; vasomotor symptoms treatment

Tue, 09/29/2026 - 3:06 PM EDT

Tue, 09/29/2026 - 3:07 PM EDT

1

pharmacologic_treatments_for_females_with_menopausal_vasomotor_symptoms_2026.pdf

{"Author":"Reyna Howkins","CreationDate":"2026-09-29T15:06:32-04:00","Creator":"Microsoft\u00ae Word for Microsoft 365","Keywords":"hormone replacement therapy; hormone therapy; menopause treatment; vasomotor symptoms; vasomotor symptoms treatment","ModDate":"2026-09-29T15:07:20-04:00","Producer":"Microsoft\u00ae Word for Microsoft 365","Subject":"The American College of Physicians (ACP) recommends estrogen in combination with progestogen (for females with a uterus) or estrogen monotherapy (for females without a uterus) as first-line treatment for perimenopausal and postmenopausal females who are seeking treatment for menopausal vasomotor symptoms (VMS), which consist of hot flashes and night sweats.\u202f","Title":"Pharmacologic Treatments for Females with Menopausal Vasomotor Symptoms: A Clinical Guideline from the American College of Physicians","Pages":1,"pdf:producer":"Microsoft\u00ae Word for Microsoft 365","pdf:keywords":"hormone replacement therapy; hormone therapy; menopause treatment; vasomotor symptoms; vasomotor symptoms treatment","xmp:creatortool":"Microsoft\u00ae Word for Microsoft 365","xmp:createdate":"2026-09-29T15:06:32-04:00","xmp:modifydate":"2026-09-29T15:07:20-04:00","xmp:metadatadate":"2026-09-29T15:07:20-04:00","xmpmm:documentid":"uuid:30D4C71B-6547-41D8-B4AF-6A7D4688DF87","xmpmm:instanceid":"uuid:203625b0-ac67-4bd6-bc85-b652422b1365","dc:format":"application\/pdf","dc:creator":"Reyna Howkins","dc:title":"Pharmacologic Treatments for Females with Menopausal Vasomotor Symptoms: A Clinical Guideline from the American College of Physicians","dc:subject":["hormone replacement therapy","hormone therapy","menopause treatment","vasomotor symptoms","vasomotor symptoms treatment"],"dc:description":"The American College of Physicians (ACP) recommends estrogen in combination with progestogen (for females with a uterus) or estrogen monotherapy (for females without a uterus) as first-line treatment for perimenopausal and postmenopausal females who are seeking treatment for menopausal vasomotor symptoms (VMS), which consist of hot flashes and night sweats.\u202f"}

2026